Preparing for the ONS/ONCC Chemotherapy Biotherapy Certificate Course – Making It Easier for You
Thursday, December 4, 2014
Registration Information
| Date | Thursday, December 4, 2014 |
|---|---|
| Time | 8:00am - 10:30am or Noon - 2:30pm or 4:00pm - 6:30pm |
| Place |
Samuel Merritt University 3100 Telegraph Avenue Professional Medical Office Building Room 4004 (4th floor) Oakland, CA 94609 |
| CEUs | 2 Contact Hours |
| Fee |
$20 per person 20% discount for 5 or more nurses registering from the same place of employment (registration forms must be submitted together) |
| Deadline | November 28, 2014 |
Registration & Refund Policy
Space is limited, and registrations will be accepted in the order in which they are received. Map, parking information and course confirmation letters will be sent via e-mail immediately upon receipt of application and payment. You must bring the confirmation with you to the course to be seated. If you have not received a confirmation within 5 days of registration, please contact the Bay Area Tumor Institute immediately. If you send/fax your registration within 5 business days or less of the registration deadline, please call the Bay Area Tumor Institute to confirm receipt. Without confirmation of receipt, you will not be admitted to the course after the deadline.
Continuing Education Credits
Provider approved by the California Board of Registered Nursing, Provider Number CEP4147, for 2 contact hours. No partial credit can be given for any course. Registrants must attend entire course to receive CE credits.
Refund Policy
Registration fees will not be refunded unless the course is canceled, and notification will be given five days prior to the program.
Bay Area Tumor Institute
The Bay Area Tumor Institute is dedicated to improving the care of cancer patients in the Bay Area. Each year, the Institute provides more than 100 hours of continuing education for physicians, nurses, and other members of the cancer care team. The Institute also provides consultations to physicians treating difficult or unusual head and neck cancer cases and, through its clinical research program, provides advanced anti-cancer drugs to patients on investigational treatment protocols. The Institute also provides opportunities for those "at risk" to participate in breast cancer and prostate cancer prevention trials.